skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Role of tipranavir in treatment of patients with multidrug-resistant HIV

Review

(1334) Views  (396) Full article downloads

Authors: Joshua D Courter, Colleen J Teevan, Michael H Li, et al

Published Date September 2010 Volume 2010:6 Pages 431 - 441
DOI: http://dx.doi.org/10.2147/TCRM.S4207

Joshua D Courter1,2, Colleen J Teevan1, Michael H Li1, Jennifer E Girotto1,2, Juan C Salazar1,2,3
1University of Connecticut School of Pharmacy, Storrs, 2Connecticut Children’s Medical Center, Hartford, 3University of Connecticut School of Medicine, Hartford, Connecticut, USA

Abstract: The worldwide emergence of multidrug-resistant human immunodeficiency virus (HIV)-1 strains has the driven the development of new antiretroviral (ARV) agents. Over the past 5 years, HIV-entry and integrase inhibitor ARVs, as well as improved non-nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs), have become available for treatment. It is important to assess how these new ARVs might be most judiciously used, paying close attention to viral susceptibility patterns, pharmacodynamic parameters, and the likelihood that patients will adhere to their therapy. Herein we review published material in Medline, EMBASE, and ISI for each antiretroviral agent/classes currently approved and summarize the available data on their efficacy, safety, and pharmacologic parameters. We focus on the role of tipranavir, a recently approved nonpeptidic PI, for treating HIV-infected children, adolescents, and adults with a history of multidrug-resistant HIV.

Keywords: tipranavir, HIV, multidrug resistance






Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Editorial
Nonpathogenic bacterial flora and immunoglobulin A in the oral cavity inhibit colonization of methicillin-resistant Staphylococcus aureus in very low birth weight infants
A review of studies concerning treatment adherence of patients with anxiety disorders
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Evaluation of factors influencing stable microbubble test results in preterm neonates at 30–33 gestational weeks
Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure
Erythrocyte sedimentation rate as a marker for coronary heart disease